1st Quarter - Report

W STRATEGIES, LLC for ASTRAZENECA PHARMACEUTICALS LP

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

H.R.1892: Bipartisan Budget Act of 2018 as it relates to a Part D donut hole provision and IPAB repeal. H.R.1625: Consolidated Appropriations Act, 2018.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1892 (115th), H.R. 1625 (115th)

Medicare/Medicaid MMM

H.R.1834: Cancer Care Payment Reform Act of 2017. Education about innovative contracting and value based payments. Synchronization and Nonadherence Correction (SYNC) Act. H.R.849/H.J.Res 51: IPAB Repeal Act and Joint Resolution related to IPAB Repeal.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.J.Res. 51 (115th), H.R. 1834 (115th), H.R. 849 (115th)

Health Issues HCR

Education about the 340(b) drug discount program including the CMS 340(b) CMP Rule. CDC Recommendations about flu treatments.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.